Standout Papers

Bupropion and Naltrexone in Methamphetamine Use Disorder 2021 2026 2022 2024139
  1. Bupropion and Naltrexone in Methamphetamine Use Disorder (2021)
    Madhukar H. Trivedi, Robrina Walker et al. New England Journal of Medicine

Immediate Impact

19 from Science/Nature 56 standout
Sub-graph 1 of 22

Citing Papers

The benefits of GLP-1 drugs beyond obesity
2024 StandoutScience
Association of GLP-1 Receptor Agonists and Hepatocellular Carcinoma Incidence and Hepatic Decompensation in Patients With Type 2 Diabetes
2024 Standout
1 intermediate paper

Works of Udi E. Ghitza being referenced

Repurposing ketamine to treat cocaine use disorder: integration of artificial intelligence‐based prediction, expert evaluation, clinical corroboration and mechanism of action analyses
2023

Author Peers

Author Last Decade Papers Cites
Udi E. Ghitza 744 1014 519 82 2.7k
Arthur Margolin 822 942 268 67 3.1k
James C. Garbutt 1626 1236 543 89 4.2k
Eugene Somoza 553 793 326 91 2.6k
Gerhard A. Wiesbeck 908 765 282 126 3.3k
Maria Lúcia Oliveira de Souza Formigoni 1041 825 444 107 3.6k
Michael Soyka 1242 708 534 132 3.0k
Joanne B. Fertig 1517 869 249 57 3.7k
John Grabowski 1057 1733 463 85 3.7k
Margaret Rukstalis 647 729 755 59 2.8k
Karen Miotto 1194 1116 919 76 3.9k

All Works

Loading papers...

Rankless by CCL
2026